ZFP36 and obesity disorder: Future studies could explore the efficacy of gene therapy or small-molecule agonists designed to upregulate or mimic ZFP36 activity in adipose tissue, testing whether such interventions can reverse or prevent obesity and insulin resistance in preclinical models.